Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Journal of Virology|August 30, 2013
The open chromatin landscape of Kaposi's sarcoma-associated herpesvirusIsaac B Hilton, Jeremy M Simon, Jason D Lieb, et al.Nucleic Acids Research|July 18, 2022
Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactionsKaiyuan Wang, Mario Escobar, Jing Li, et al.Elife|January 12, 2026
Predicting the effect of CRISPR-Cas9-based epigenome editingSanjit Singh Batra, Alan Cabrera, Jeffrey P Spence, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
Predicting the effect of CRISPR-Cas9-based epigenome editingSanjit Singh Batra, Alan Cabrera, Jeffrey P Spence, et al.Frontiers in Immunology|June 24, 2021
Reversing Post-Infectious Epigenetic-Mediated Immune SuppressionAbhimanyu, Carlos O Ontiveros, Rosa S Guerra-Resendez, et al.Nature Biotechnology|April 8, 2015
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancersIsaac B Hilton, Anthony M D'Ippolito, Christopher M Vockley, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Robust fluorescent labeling and tracking of endogenous non-repetitive genomic lociAlex Raterink, Rajarshi P Ghosh, Linfeng Yang, et al.Nature Biotechnology|April 4, 2017
CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genomeTyler S Klann, Joshua B Black, Malathi Chellappan, et al.Cancer Research|February 6, 2013
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesisDebasmita Roy, Sang-Hoon Sin, Amy Lucas, et al.Science Advances|August 25, 2020
Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effectsSangsin Lee, Ning Ding, Yidi Sun, et al.Pageof 4